Nrx pharmaceuticals (nasdaq: nrxp) announces participation in the noblecon20 - noble capital markets' twentieth annual emerging growth equity conference december 3-4, 2024

Wilmington, del., nov. 26, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that dr. jonathan javitt, chairman, ceo and chief scientist will present at noblecon20 - noble capital markets' twentieth annual emerging growth equity conference at florida atlantic university, executive education complex, in boca raton, fl.
NRXP Ratings Summary
NRXP Quant Ranking